Renova Therapeutics Overview

  • Founded
  • 2009
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Renova Therapeutics General Information

Description

Operator of bio-pharmaceutical research company designed to create a portfolio of definitive gene and peptide therapies. The company's bio-pharmacy is engaged in research and development of gene and peptide therapies, single-dose gene therapies and peptide infusion treatment, enabling medical professionals to treat congestive heart failure (CHF) and type 2 diabetes..

Contact Information

Website
www.renovatherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 11455 El Camino Real
  • Suite 350
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Renova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Feb-2019 000.00 Completed Out of Business
6. Later Stage VC (Series D) 01-Mar-2016 0000 000.00 00000 Completed Generating Revenue
5. Grant 23-Feb-2016 00000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 18-Nov-2014 00.000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 04-Oct-2012 00.000 00.00 0000 Completed Product Development
2. Early Stage VC (Series A) $3.05M $3.05M 000.00 Completed Startup
1. Grant 02-Sep-2011 $250K Completed Startup
To view Renova Therapeutics’s complete valuation and funding history, request access »

Renova Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D 000,000 00.000000 00.0 0000.00 0000.00 00 0000.00 0.000
Series C 000,000 00.000000 00.00 000.0 000.0 00 000.0 00.000
Series B 320,292 $0.001000 $1.23 $24.6 $24.6 1x $24.6 14.17%
Series A 305,000 $0.001000 $0.5 $10 $10 1x $10 13.49%
To view Renova Therapeutics’s complete cap table history, request access »

Renova Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of bio-pharmaceutical research company designed to create a portfolio of definitive gene and peptide therapies.
Biotechnology
San Diego, CA
000.00
00000000 00 000.00

000000 0

mpor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000 000000000
Sarasota, FL
00 As of 0000
00000
0000 0000-00-00
0000000000 0 00000

00000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000 000000000
Boston, MA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Renova Therapeutics Competitors (48)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DalCor Pharmaceuticals Venture Capital-Backed Sarasota, FL 00 00000 0000000000 0 00000
00000000000 Venture Capital-Backed Boston, MA 00 00000 00000000000 00000
00000000 Venture Capital-Backed Tübingen, Germany 000 00000 000000000000 00000
000000000 (0000 00 Venture Capital-Backed Stevenage, United Kingdom 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
You’re viewing 5 of 48 competitors. Get the full list »

Ready to get started?

Request a free trial